Table 4.
Distribution of demographic, clinical, and neurological examination in patients with CKD with and without peripheral neuropathy.
| Polyneuropathy | Test of sig | P-value | ||||
|---|---|---|---|---|---|---|
|
Yes N = 11 |
No N = 39 |
|||||
| Mean ± SD | Mean ± SD | |||||
| Age (Years) | 11.36 ± 3.35 | 12.28 ± 3.50 | 0.75 | 0.450 | ||
| Sex | ||||||
| Male | 4 | 36.4 | 19 | 48.7 | 0.52 | 0.468 |
| Female | 7 | 63.6 | 20 | 51.3 | ||
| Seizure | 2 | 18.2 | 9 | 23.1 | 0.12 | 1.0 |
| Headache | 3 | 27.3 | 9 | 23.1 | 0.08 | 1.0 |
| Numbness | 9 | 81.8 | 0 | 0.0 | 38.91 | <0.001* |
| Dizziness | 0 | 0.0 | 5 | 12.8 | 1.56 | 0.573 |
| Insomnia | 2 | 18.2 | 5 | 12.8 | 0.20 | 0.641 |
| EEG abnormality | 3 | 27.3 | 6 | 15.4 | 0.82 | 0.392 |
| MRI abnormality | 3 | 27.3 | 5 | 12.8 | 1.33 | 0.351 |
| Albumin (g/dL) | 4.88 ± 0.25 | 4.08 ± 0.27 | ||||
| Median | 4.90 | 4.0 | 4.83 | <0.001* | ||
| IQR | 4.60–5.10 | 3.80–4.30 | ||||
| eGFR (ml/min/1.73 m2) | 16.63 ± 3.23 | 25.74 ± 1.66 | ||||
| Median | 16.0 | 26.0 | 5.07 | <0.001* | ||
| IQR | 14–20 | 25–27 | ||||
| Creatinine (mg/dl) | 8.31 ± 0.64 | 6.25 ± 0.81 | ||||
| Median | 8.20 | 6.30 | 5.01 | <0.001* | ||
| IQR | 7.80–8.90 | 5.70–7.0 | ||||
ann-Whitney test; CV, Conduction velocity; Rt, right; Lt, left;
*
significant.
Bold values indicates significant p-values.